|
Volumn 50, Issue 6, 2000, Pages 591-595
|
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride
a a a a |
Author keywords
CYP2C9; Glimepiride; Interaction; Rifampicin
|
Indexed keywords
ANTIDIABETIC AGENT;
CYTOCHROME P450 2C9;
GLIMEPIRIDE;
GLUCOSE;
RIFAMPICIN;
RIFARM;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HUMAN EXPERIMENT;
HYPOGLYCEMIA;
MALE;
NORMAL HUMAN;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTIBIOTICS, ANTITUBERCULAR;
BLOOD GLUCOSE;
CROSS-OVER STUDIES;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
RIFAMPIN;
SULFONYLUREA COMPOUNDS;
|
EID: 0034537330
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2125.2000.00295.x Document Type: Article |
Times cited : (46)
|
References (12)
|